TC
SRNE

TownSquare Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

TownSquare Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,765
Closed -$97K – 787
2021
Q3 		$97K Hold
12,765
– – ﹤0.01% 689
2021
Q2 		$121K Hold
12,765
– – ﹤0.01% 600
2021
Q1 		$106K Buy
12,765
+100
+0.8% +$1.06K ﹤0.01% 551
2020
Q4 		$86K Hold
12,665
– – ﹤0.01% 484
2020
Q3 		$134K Sell
12,665
-200
-2% -$1.83K 0.01% 412
2020
Q2 		$99K Buy
+12,865
New +$49.3K 0.01% 393

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TownSquare Capital's SRNE Position: Q4 2021 in Review

TownSquare Capital sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 12,765 shares — an estimated $97K sold.

TownSquare Capital first reported a position in SRNE in Q2 2020 and held it in 6 quarters. The position peaked at $134K in Q3 2020. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • TownSquare Capital reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • TownSquare Capital sold 12,765 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $97K.
  • TownSquare Capital first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
  • TownSquare Capital's Sorrento Therapeutics, Inc. position peaked at $134K in Q3 2020.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on TownSquare Capital's 13F filing for Q4 2021, filed 11 Feb 2022.